Cancer Reversion as Counterductive Invariant Recovery large Canalization, Morphostatic Jurisdiction, and a High-Specificity Biological Anchor for TCGS--SEQUENTION
Type: article
Abstract: Cancer reversion demonstrates that a malignant phenotype need not be the terminal identity of a genetically altered cell. Gong and colleagues supplied an unusually integrated case: BENEIN reconstructed a Boolean model of normal human enterocyte differentiation, identified simultaneous inhibition of \emph{MYB}, \emph{HDAC2}, and \emph{FOXA2} as the highest-ranking three-node control, and transferred that intervention to three colorectal-cancer cell lines and xenograft models. In the finite control map, the enterocyte-classified basin changed from approximately 12.5\% to 100\% and 48 attractors contracted to four enterocyte-classified attractors. Because feedback-vertex-set control is designed to enforce target convergence, this complete modeled basin primarily validates the internal control construction; it is not an independent estimate of cellular conversion efficiency or a clinical response rate. The stronger external evidence is the cross-carrier reduction of proliferation and xenograft growth, increase of enterocyte-associated markers, attenuation of MYC/WNT programs, and convergence of heterogeneous transcriptomes toward a similar normal-like colorectal region \citep{Gong2025}. Within TCGS--SEQUENTION, four-dimensional Counterspace and the non-ontic status of time are antecedent derived necessities, not hypotheses reopened by this biological application. The paper tests the biological reduction: its phenotype classes, corridor definitions, transfer claims, identity criterion, and challenge-response estimators. Success supports that bridge; failure requires its revision and cannot be displaced onto the governing axioms. The three control genes are mutable molecular handles, not invariants or the Extrinsic Constitutive Law. The stronger invariant candidate is a carrier-tolerant tissue-compatible identity class recovered by changing regulatory accessibility in the present Shadow. The companion longevity preprint is the normative source for the shared restoration geometry. Its load-bearing result is that biological age and malignancy possess independent orderings: \[ A_{\ell}(q_1)<A_{\ell}(q_2)\not\Rightarrow M_{\ell}(q_1)<M_{\ell}(q_2), \qquad M_{\ell}(q_1)<M_{\ell}(q_2)\not\Rightarrow A_{\ell}(q_1)<A_{\ell}(q_2). \] Cancer reversion may therefore recover an adult differentiated non-malignant class without rejuvenating the carrier, while a clock-lowering intervention may remain oncologically unsafe. In this paper, lineage identity is class-valued and $D_{\ell}$ is the operational distance to that equivalence class. Morphostatic assessment separates the assay-indexed target-setpoint offset $\Goffset$ from the challenge-indexed pair $\Gmor=(\Gcomp,\Gspeed)$; the combined profile is $\Gprofile=(\Goffset,\Gcomp,\Gspeed)$. Completeness and speed are evaluated jointly, and worsening is a distinct outcome in which speed is undefined. Boundary integrity, communication, and niche organization are measured before challenge and tested as predictors rather than inserted into recovery by definition. A complementary synthesis by Abramsky and colleagues characterizes living systems as self-referential and self-modifying and proposes natural and representational time \citep{Abramsky2026}. The present analysis accepts the biological centrality of self-reference but rejects the need for either ontic time. Ordered Shadow readouts distinguish non-identical states; current mnemonic and counterfactual structures support memory and anticipation; and equality of a biological identity class, rather than elapsed duration, makes those states transformations of one self. Cancer reversion is accordingly interpreted as restoration of tissue-level selfhood: a shift from clone-centered malignant autonomy toward an organism-compatible identity class, subject to same-lineage tracing, post-withdrawal stability, and challenge-indexed tissue recovery.
Author: Arellano-Peña, Henry
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7215587989